Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
Merck(MRK) stock is priced at $122.38, giving the company a market capitalization of 302.26B. It carries a P/E multiple of 32.61 and pays a dividend yield of 2.9%.
On 2026-05-22, Merck(MRK) stock moved within a range of $118.97 to $122.66. With shares now at $122.38, the stock is trading +2.9% above its intraday low and -0.2% below the session's peak.
Trading volume for Merck(MRK) stock has reached 9.8M, versus its average volume of 7.82M.
The stock's 52-week range extends from a low of $75.40 to a high of $125.14.
The stock's 52-week range extends from a low of $75.40 to a high of $125.14.
MRK News
Merck (MRK) has drawn fresh attention after reporting Phase 3 success for its investigational antibody drug conjugate sacituzumab tirumotecan in advanced or rec...
Biotech and Pharma Merck Stock Climbs on Cancer Data. Why the Drugmaker Is More Than a One-Trick Pony. In this article MRK 6990 SPX PFE 4503 Merck and Sichuan K...
Merck (MRK) announced the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion recommending approval of KEYTRUD...
Analyst ratings
70%
of 30 ratingsMore MRK News
Chinese biopharma company Kelun-Biotech announced on Thursday that an antibody drug conjugate it is developing with Merck (MRK), with Keytruda, outperformed the...
Exelixis (EXEL) announced that the company has entered into a clinical development collaboration with Merck (MRK), known as MSD outside of the United States and...
Merck (MRK) announced the pivotal Phase 3 TroFuse-005 trial evaluating sacituzumab tirumotecan, or sac-TMT, an investigational TROP2-directed antibody-drug conj...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.